Evidence map›Paper›PMID 26684815›Full record

ArticleBMC public health2015

Non-fatal overdoses and related risk factors among people who inject drugs in St. Petersburg, Russia and Kohtla-Järve, Estonia.

Anneli Uusküla, Mait Raag, Sigrid Vorobjov, Kristi Rüütel, Alexandra Lyubimova, Olga S Levina, Robert Heimer

Open access · goldAbstract read
In one paragraph

Article in BMC public health, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 3 pooled it
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 3 syntheses or guidelines pooled it, 34 citations in OpenAlex.

  1. A Review of Network Models for HIV Spread.Journal of acquired immune deficiency syndromes (1999) · 2025
    Pooled it
  2. Pooled it
  3. HIV seroprevalence in five key populations in Europe: a systematic literature review, 2009 to 2019.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2021
    Pooled it
  4. Article
  5. Article
  6. Understanding Naloxone Uptake from an Emergency Department Distribution Program Using a Low-Energy Bluetooth Real-time Location System.Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2020
    Observational
  7. Article
  8. A Pilot Study of a Telemedicine-based Substance Use Disorder Evaluation to Enhance Access to Treatment Following Near-Fatal Opioid Overdose.Proceedings of the ... Annual Hawaii International Conference on System Sciences. Annual Hawaii International Conference on System Sciences · 2020
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Anneli UuskülaDepartment of Public Health, University of Tartu, Ravila st 19, 50409, Tartu, Estonia. anneli.uuskula@ut.ee.
Mait RaagDepartment of Public Health, University of Tartu, Ravila st 19, 50409, Tartu, Estonia. mait.raag@ut.ee.
Sigrid VorobjovInfectious Diseases and Drug Monitoring Department, National Institute for Health Development, Hiiu 42, 11619, Tallinn, Estonia. sigrid.vorobjov@tai.ee.
Kristi RüütelInfectious Diseases and Drug Monitoring Department, National Institute for Health Development, Hiiu 42, 11619, Tallinn, Estonia. kristi.ruutel@tai.ee.
Alexandra LyubimovaNGO Stellit, St Petersburg, Russian Federation. alexandra.lyubimova@gmail.com.
Olga S LevinaNGO Stellit, St Petersburg, Russian Federation. spring2005.05@mail.ru.
Robert HeimerDepartment of Epidemiology of Microbial Diseases and the Center for Interdisciplinary Research on AIDS, Yale University School of Public Health, 60 College St, New Haven, CT, 06510, USA. robert.heimer@yale.edu.
National Institute for Health Development · EEUniversity of Tartu · EEYale University · US

Funding

Influences on HIV Prevalence and Service Access among IDUs in Russia and EstoniaR01DA029888 · NIDA · YALE UNIVERSITY · PI HEIMER, ROBERT, UUSKULA, ANNELI · 2010 to 2014
$2.0M
NIDA NIH HHS R01 DA029888
6 · The paper itself

Abstract

backgroundThis study seeks to identify the prevalence of, and risk factors associated with, non-fatal overdose among people currently injecting drugs (PWID) in St. Petersburg (Russia) and in Kohtla-Järve (Estonia).

methodsFive hundred eighty-eight study participants in Kohtla-Järve (in 2012) and 811 in St. Petersburg (in 2012-2013) were recruited using respondent driven sampling for interviewing and HIV testing.

resultsThree-quarters (76%) of the current PWID were male. Participants from St. Petersburg were older (mean age 32.1 vs. 29.6 years, p < 0.0001) and reported a longer average duration of injecting drugs (mean duration: 13.3 vs. 10.9 years, p < 0.0001). Main drugs injected were opioids (fentanyl in Kohtla-Järve, heroin in St Petersburg). HIV prevalence was 63% (95% CI 59-67%) in Kohtla-Järve and 56% (95% CI 52-59%) in St. Petersburg. Two thirds of the PWID in Kohtla-Järve and St. Petersburg reported ever having experienced a drug overdose involving loss of consciousness or stopping breathing. In Kohtla-Järve, 28% (95% CI 24-31%) of participants and, in St Petersburg, 16% (95% CI 14-19%) of participants reported an overdose within the previous 12 months. Characteristics of injection drug use practice (longer duration of injection drug use, main drug injected), correlates of high-risk injection behaviour (higher injecting frequency, sharing), and problem alcohol use were associated with the risk of overdose within the previous 12 months. The significant factors effects did not differ between the sites.

conclusionsPWID are at high risk for overdose. Effective overdose prevention efforts at the public health scale are therefore warranted.

Indexed as

Risk-TakingAdultAlcoholismComorbidityCross-Sectional StudiesDrug OverdoseEstoniaFemaleHIV InfectionsHumansMaleMinority GroupsPrevalenceRacial GroupsRisk FactorsRussia

Identifiers

PMID26684815
PMCPMC4683801
OpenAlexW2215849244

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.